ICD-10 Diagnosis Code T45.1X5A

Adverse effect of antineoplastic and immunosup drugs, init

Diagnosis Code T45.1X5A

ICD-10: T45.1X5A
Short Description: Adverse effect of antineoplastic and immunosup drugs, init
Long Description: Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
This is the 2018 version of the ICD-10-CM diagnosis code T45.1X5A

Valid for Submission
The code T45.1X5A is valid for submission for HIPAA-covered transactions.

Code Classification
  • Injury, poisoning and certain other consequences of external causes (S00–T98)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
      • Primarily systemic and hematological agents, NEC (T45)

Information for Medical Professionals

Code Edits
The following edits are applicable to this code:
Unacceptable principal diagnosis Additional informationCallout TooltipUnacceptable principal diagnosis
There are selected codes that describe a circumstance which influences an individual’s health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Convert to ICD-9 Additional informationCallout TooltipGeneral Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Accelerated rheumatoid nodulosis
  • Accelerated rheumatoid nodulosis due to methotrexate
  • Aclarubicin adverse reaction
  • Acral erythema
  • Acral erythema due to cytotoxic therapy
  • Adverse reaction caused by antineoplastic antibiotics
  • Adverse reaction caused by drug or medicament administered by infusion
  • Adverse reaction caused by drug or medicament administered by infusion
  • Adverse reaction caused by rituximab administered by infusion
  • Adverse reaction caused by trastuzumab administered by infusion
  • Aldesleukin adverse reaction
  • Alkylating drug adverse reaction
  • Amifostine adverse reaction
  • Amsacrine adverse reaction
  • Antimetabolite adverse reaction
  • Antineoplastic adverse reaction
  • Aplastic anemia caused by antineoplastic agent
  • Aplastic anemia due to drugs
  • Azathioprine adverse reaction
  • Bleomycin adverse reaction
  • Busulfan adverse reaction
  • Carboplatin adverse reaction
  • Carmustine adverse reaction
  • Cellular atypia caused by antineoplastic agent
  • Chemotherapy sickness
  • Chemotherapy-induced neutropenia
  • Chlorambucil adverse reaction
  • Chronic cyclosporin A nephrotoxicity
  • Chronic drug-induced renal disease
  • Chronic drug-induced renal disease
  • Chronic drug-induced renal disease
  • Cisplatin adverse reaction
  • Cis-platinum nephropathy
  • Complication of chemotherapy
  • Complication of chemotherapy
  • Crisantaspase adverse reaction
  • Cutaneous ulceration caused by cytotoxic therapy
  • Cyclophosphamide adverse reaction
  • Cyclosporin adverse reaction
  • Cytarabine adverse reaction
  • Cytotoxic antibiotic adverse reaction
  • Dacarbazine adverse reaction
  • Dactinomycin adverse reaction
  • Dermatosis resulting from immunosuppressive therapy
  • Dimethyl sulfoxide adverse reaction
  • Doxorubicin adverse reaction
  • Drug-induced mucositis
  • Drug-induced mucositis
  • Drug-induced neutropenia
  • Epirubicin adverse reaction
  • Esophagitis medicamentosa
  • Estramustine adverse reaction
  • Ethoglucid adverse reaction
  • Etoposide adverse reaction
  • Fatigue due to chemotherapy or radiation therapy
  • Fatigue due to treatment
  • Fludarabine adverse reaction
  • Fluorouracil adverse reaction
  • Gonad regulating hormone adverse reaction
  • Gonad regulating hormone adverse reaction
  • Gonad regulating hormone adverse reaction
  • Goserelin adverse reaction
  • Hydroxyurea adverse reaction
  • Idarubicin adverse reaction
  • Ifosfamide adverse reaction
  • Immunodeficiency secondary to chemotherapy
  • Immunosuppressant adverse reaction
  • Inflammation of esophagus due to chemotherapy
  • Leuprorelin adverse reaction
  • Lomustine adverse reaction
  • Malignant neoplasm after immunosuppressive therapy
  • Melphalan adverse reaction
  • Mercaptopurine adverse reaction
  • Methotrexate adverse reaction
  • Methotrexate poisoning
  • Methotrexate skin ulceration
  • Methyl lomustine nephropathy
  • Mitobronitol adverse reaction
  • Mitomycin adverse reaction
  • Mitozantrone adverse reaction
  • Mucositis following chemotherapy
  • Mucositis following therapy
  • Mustine adverse reaction
  • Nausea and vomiting
  • Nephropathy caused by ciclosporin
  • Nephropathy caused by tacrolimus
  • Neurotoxicity
  • Neurotoxicity
  • Neurotoxicity
  • Neurotoxicity
  • Neurotoxicity
  • Neurotoxicity caused by L-asparaginase
  • Neurotoxicity caused by methotrexate
  • Neurotoxicity caused by procarbazine
  • Neurotoxicity caused by vinblastine
  • Neurotoxicity caused by vincristine
  • Nitrogen mustard derivative adverse reaction
  • Nitrosurea adverse reaction
  • Oral ulcerative mucositis due to antineoplastic therapy
  • Paclitaxel adverse reaction
  • Pentostatin adverse reaction
  • Peripheral neuropathy due to chemotherapy
  • Plicamycin adverse reaction
  • Poisoning caused by L-asparaginase
  • Procarbazine adverse reaction
  • Procarbazine poisoning
  • Razoxane adverse reaction
  • Retinoid adverse reaction
  • Rheumatoid nodulosis
  • Secondary aplastic anemia
  • Stomatitis caused by cytotoxic therapy
  • Stomatitis medicamentosa
  • Stomatitis medicamentosa
  • Subcutaneous rheumatoid nodule
  • Terpenes adverse reaction
  • Terpenes adverse reaction
  • Thioguanine adverse reaction
  • Thiotepa adverse reaction
  • Thrombophilia caused by antineoplastic agent therapy
  • Thrombophilia caused by drug therapy
  • Treosulfan adverse reaction
  • Triazene antineoplastic adverse reaction
  • Triptorelin adverse reaction
  • Ulcerative stomatitis
  • Vinblastine adverse reaction
  • Vinblastine poisoning
  • Vinca alkaloid adverse reaction
  • Vincristine adverse reaction
  • Vincristine poisoning
  • Vindesine adverse reaction

Information for Patients

Drug Reactions

Also called: Side effects

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions.

One problem is interactions, which may occur between

  • Two drugs, such as aspirin and blood thinners
  • Drugs and food, such as statins and grapefruit
  • Drugs and supplements, such as ginkgo and blood thinners
  • Drugs and diseases, such as aspirin and peptic ulcers

Interactions can change the actions of one or both drugs. The drugs might not work, or you could get side effects.

Side effects are unwanted effects caused by the drugs. Most are mild, such as a stomach aches or drowsiness, and go away after you stop taking the drug. Others can be more serious.

Drug allergies are another type of reaction. They can be mild or life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is more rare.

When you start a new prescription or over-the-counter medication, make sure you understand how to take it correctly. Know which other medications and foods you need to avoid. Ask your health care provider or pharmacist if you have questions.

  • Angioedema (Medical Encyclopedia)
  • Drug allergies (Medical Encyclopedia)
  • Drug-induced diarrhea (Medical Encyclopedia)
  • Drug-induced tremor (Medical Encyclopedia)
  • Taking multiple medicines safely (Medical Encyclopedia)

[Read More]
Previous Code
Previous Code T45.1X5
Next Code
T45.1X5D Next Code